QSAR modeling with the electrotopological state: TIBO derivatives

Area of Science:

• Medicinal Chemistry
• Computational Chemistry
• Virology

Background:

• HIV-1 reverse transcriptase (HIV-1 RT) is a key target for antiviral drug development.
• TIBO derivatives are a class of compounds investigated for their anti-HIV activity.
• Understanding structure-activity relationships is crucial for designing potent inhibitors.

Purpose of the Study:

• To develop a quantitative structure-activity relationship (QSAR) model for TIBO derivatives targeting HIV-1 RT.
• To identify key molecular descriptors influencing the affinity of TIBO derivatives.
• To predict the anti-HIV activity of novel TIBO derivatives.

Main Methods:

• Utilized multiple linear regression techniques for QSAR model development.
• Employed atom-level E-state indices and calculated molecular properties (log P, MR) as descriptors.
• Validated the model using regression statistics and leave-one-out cross-validation on training and test sets.

Main Results:

• A QSAR model incorporating four atom-level E-state indices and log P demonstrated strong predictive power.
• The model achieved high correlation coefficients (r2 = 0.85 for training, r2 = 0.80 for testing) and low standard errors.
• Key descriptors indicated significant lipophilic and electronic contributions to HIV-1 RT inhibition.

Conclusions:

• The developed QSAR model effectively predicts the anti-HIV activity of TIBO derivatives.
• Lipophilicity and electronic properties are critical determinants of TIBO derivative efficacy against HIV-1 RT.
• This model can guide the design of new, more potent anti-HIV agents.